158 related articles for article (PubMed ID: 23628990)
1. An orthotopic mouse model of anaplastic thyroid carcinoma.
Sewell W; Reeb A; Lin RY
J Vis Exp; 2013 Apr; (74):. PubMed ID: 23628990
[TBL] [Abstract][Full Text] [Related]
2. Characterization of thyroid cancer cell lines in murine orthotopic and intracardiac metastasis models.
Morrison JA; Pike LA; Lund G; Zhou Q; Kessler BE; Bauerle KT; Sams SB; Haugen BR; Schweppe RE
Horm Cancer; 2015 Jun; 6(2-3):87-99. PubMed ID: 25800363
[TBL] [Abstract][Full Text] [Related]
3. An orthotopic model of anaplastic thyroid carcinoma in athymic nude mice.
Kim S; Park YW; Schiff BA; Doan DD; Yazici Y; Jasser SA; Younes M; Mandal M; Bekele BN; Myers JN
Clin Cancer Res; 2005 Mar; 11(5):1713-21. PubMed ID: 15755992
[TBL] [Abstract][Full Text] [Related]
4. A novel orthotopic mouse model of human anaplastic thyroid carcinoma.
Nucera C; Nehs MA; Mekel M; Zhang X; Hodin R; Lawler J; Nose V; Parangi S
Thyroid; 2009 Oct; 19(10):1077-84. PubMed ID: 19772429
[TBL] [Abstract][Full Text] [Related]
5. Real-time, high-resolution imaging of tumor cells in genetically engineered and orthotopic models of thyroid cancer.
Shanja-Grabarz X; Coste A; Entenberg D; Di Cristofano A
Endocr Relat Cancer; 2020 Oct; 27(10):529-539. PubMed ID: 32698130
[TBL] [Abstract][Full Text] [Related]
6. Development and optimization of orthotopic liver metastasis xenograft mouse models in uveal melanoma.
Sugase T; Lam BQ; Danielson M; Terai M; Aplin AE; Gutkind JS; Sato T
J Transl Med; 2020 May; 18(1):208. PubMed ID: 32434572
[TBL] [Abstract][Full Text] [Related]
7. Modeling the tumor microenvironment of anaplastic thyroid cancer: an orthotopic tumor model in C57BL/6 mice.
Xu Z; Shin HS; Kim YH; Ha SY; Won JK; Kim SJ; Park YJ; Parangi S; Cho SW; Lee KE
Front Immunol; 2023; 14():1187388. PubMed ID: 37545523
[TBL] [Abstract][Full Text] [Related]
8. Growth-inhibitory effects of human anti-insulin-like growth factor-I receptor antibody (A12) in an orthotopic nude mouse model of anaplastic thyroid carcinoma.
Wang Z; Chakravarty G; Kim S; Yazici YD; Younes MN; Jasser SA; Santillan AA; Bucana CD; El-Naggar AK; Myers JN
Clin Cancer Res; 2006 Aug; 12(15):4755-65. PubMed ID: 16899627
[TBL] [Abstract][Full Text] [Related]
9. Sorafenib inhibits the angiogenesis and growth of orthotopic anaplastic thyroid carcinoma xenografts in nude mice.
Kim S; Yazici YD; Calzada G; Wang ZY; Younes MN; Jasser SA; El-Naggar AK; Myers JN
Mol Cancer Ther; 2007 Jun; 6(6):1785-92. PubMed ID: 17575107
[TBL] [Abstract][Full Text] [Related]
10. Establishment of and comparison between orthotopic xenograft and subcutaneous xenograft models of gallbladder carcinoma.
Du Q; Jiang L; Wang XQ; Pan W; She FF; Chen YL
Asian Pac J Cancer Prev; 2014; 15(8):3747-52. PubMed ID: 24870787
[TBL] [Abstract][Full Text] [Related]
11. A bone metastases model of anaplastic thyroid carcinoma in athymic nude mice.
Zhang L; Wang H; Liang S; Ma C
Q J Nucl Med Mol Imaging; 2015 Sep; 59(3):351-6. PubMed ID: 25069676
[TBL] [Abstract][Full Text] [Related]
12. Non‑invasive monitoring of paclitaxel and lenvatinib efficacy against anaplastic thyroid cancer in orthotopic SCID mouse models using small‑animal FDG‑PET/CT.
Aoyama M; Takizawa H; Otani T; Inoue S; Kawakita N; Tsuboi M; Bando Y; Uehara H; Kondo K; Tangoku A
Oncol Rep; 2020 Oct; 44(4):1709-1716. PubMed ID: 32945510
[TBL] [Abstract][Full Text] [Related]
13. Mouse Model of Thyroid Cancer Progression and Dedifferentiation Driven by STRN-ALK Expression and Loss of p53: Evidence for the Existence of Two Types of Poorly Differentiated Carcinoma.
Nikitski AV; Rominski SL; Condello V; Kaya C; Wankhede M; Panebianco F; Yang H; Altschuler DL; Nikiforov YE
Thyroid; 2019 Oct; 29(10):1425-1437. PubMed ID: 31298630
[No Abstract] [Full Text] [Related]
14. Real-time imaging of tumor progression in a fluorescent orthotopic mouse model of thyroid cancer.
Tran Cao HS; Kaushal S; Snyder CS; Ongkeko WM; Hoffman RM; Bouvet M
Anticancer Res; 2010 Nov; 30(11):4415-22. PubMed ID: 21115887
[TBL] [Abstract][Full Text] [Related]
15. Development of orthotopic pancreatic tumor mouse models.
Qiu W; Su GH
Methods Mol Biol; 2013; 980():215-23. PubMed ID: 23359156
[TBL] [Abstract][Full Text] [Related]
16. The tyrosine kinase inhibitor, AZD2171, inhibits vascular endothelial growth factor receptor signaling and growth of anaplastic thyroid cancer in an orthotopic nude mouse model.
Gomez-Rivera F; Santillan-Gomez AA; Younes MN; Kim S; Fooshee D; Zhao M; Jasser SA; Myers JN
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4519-27. PubMed ID: 17671138
[TBL] [Abstract][Full Text] [Related]
17. Establishment of an orthotopic prostate cancer xenograft mouse model using microscope-guided orthotopic injection of LNCaP cells into the dorsal lobe of the mouse prostate.
Liu W; Zhu Y; Ye L; Zhu Y; Wang Y
BMC Cancer; 2022 Feb; 22(1):173. PubMed ID: 35168543
[TBL] [Abstract][Full Text] [Related]
18. The PLK1 inhibitor GSK461364A is effective in poorly differentiated and anaplastic thyroid carcinoma cells, independent of the nature of their driver mutations.
Russo MA; Kang KS; Di Cristofano A
Thyroid; 2013 Oct; 23(10):1284-93. PubMed ID: 23509868
[TBL] [Abstract][Full Text] [Related]
19. Growth inhibition of orthotopic anaplastic thyroid carcinoma xenografts in nude mice by PTK787/ZK222584 and CPT-11.
Kim S; Yazici YD; Barber SE; Jasser SA; Mandal M; Bekele BN; Myers JN
Head Neck; 2006 May; 28(5):389-99. PubMed ID: 16388530
[TBL] [Abstract][Full Text] [Related]
20. Hypofractionated Radiotherapy Is Superior to Conventional Fractionation in an Orthotopic Model of Anaplastic Thyroid Cancer.
Oweida A; Phan A; Vancourt B; Robin T; Hararah MK; Bhatia S; Milner D; Lennon S; Pike L; Raben D; Haugen B; Pozdeyev N; Schweppe R; Karam SD
Thyroid; 2018 Jun; 28(6):739-747. PubMed ID: 29774792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
